bio business - MARKETING
Nasdaq: Climb Bio, Inc. Appoints Perrin Wilson, Ph.D. as Chief Business Officer Climb Bio appointed Dr.
Understanding the Context
Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr. Seeking Alpha: Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results CHICAGO--(BUSINESS WIRE)--Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical ...
Image Gallery
Key Insights
Nasdaq: YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio, Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of ...